Male circumcision for HIV prevention: Current research and programmatic issues

AIDS

Volumn 24, Issue SUPPL. 4, 2010, Pages

  Weiss, Helen A ^a   Dickson, Kim E ^b   Agot, Kawango ^c   Hankins, Catherine A ^d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c IMPACT RESEARCH AND DEVELOPMENT ORGANIZATION   (Kenya)

^d UNAIDS   (Switzerland)

Author keywords

HIV; male circumcision; prevention

Indexed keywords

AFRICA; ANUS INTERCOURSE; CIRCUMCISION; GENITAL ULCER; HEALTH PROGRAM; HEALTH PROMOTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE HOMOSEXUAL; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SAFE SEX; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SEXUAL SATISFACTION; SEXUALLY TRANSMITTED DISEASE; TRICHOMONAS VAGINALIS; WART VIRUS; WOUND HEALING;

ADULT; AFRICA SOUTH OF THE SAHARA; CIRCUMCISION, MALE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEXUALLY TRANSMITTED DISEASES;

EID: 78349239238     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/01.aids.0000390708.66136.f4     Document Type: Review

References (79)

1. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007; 369:657-666.
2. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369:643-656.
3. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005; 2:e298.
4. Price LB, Liu CM, Johnson KE, Aziz M, Lau MK, Bowers J, et al. The effects of circumcision on the penis microbiome. PLoS One 2010; 5:e8422.
5. Gray RH, Kigozi G, Serwadda D, Makumbi F, Nalugoda F, Watya S, et al. The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am J Obstet Gynecol 2009; 200:42.e41-42.e47.
6. Donoval BA, Landay AL, Moses S, Agot K, Ndinya-Achola JO, Nyagaya EA, et al. HIV-1 target cells in foreskins of African men with varying histories of sexually transmitted infections. Am J Clin Pathol 2006; 125:386-391.
7. McCoombe SG, Short RV. Potential HIV-1 target cells in the human penis. AIDS 2006; 20:1491-1495.
8. Patterson BK, Landay A, Siegel JN, Flener Z, Pessis D, Chaviano A, et al. Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in ex-plant culture. Am J Pathol 2002; 161:867-873.
9. Szabo R, Short RV. How does male circumcision protect against HIV infection? BMJ 2000; 320:1592-1594.
10. Dinh MH, McRaven MD, Kelley Z, Penugonda S, Hope TJ. Keratinization of the adult male foreskin and implications for male circumcision. AIDS 2010; 24:899-906.
11. Kigozi G, Wawer M, Ssettuba A, Kagaayi J, Nalugoda F, Watya S, et al. Foreskin surface area and HIV acquisition in Rakai, Uganda (size matters). AIDS 2009; 23:2209-2213.
12. Johnson KE, Sherman ME, Ssempiija V, Tobian AA, Zenilman JM, Duggan MA, et al. Foreskin inflammation is associated with HIV and herpes simplex virus type-2 infections in Rakai, Uganda. AIDS 2009; 23:1807-1815.
13. Weiss HA, HalperinD,Bailey RC, Hayes RJ, SchmidG,Hankins CA. Male circumcision for HIV prevention: from evidence to action? AIDS 2008; 22:567-574. (Pubitemid 351640589)
14. Shaffer DN, Ngetich IK, Bautista CT, Sawe FK, Renzullo PO, Scott PT, et al. HIV-1 incidence rates and risk factors in agricultural workers and dependents in rural Kenya: 36-month follow-up of the Kericho HIV Cohort Study. J Acquir Immune Defic Syndr 2010; 53:514-521.
15. Botros BA, Aliyev QM, Saad MD, Michael AA, Sanchez JL, Carr JK, et al. HIV infection and associated risk factors among longdistance truck drivers travelling through Azerbaijan. Int J STD AIDS 2009; 20:477-482.
16. Connolly C, Simbayi LC, Shanmugam R, Nqeketo A. Male circumcision and its relationship to HIV infection in South Africa: results of a national survey in 2002. S Afr Med J 2008; 98:789-794.
17. Brewer DD, Potterat JJ, Roberts JM Jr, Brody S. Male and female circumcision associated with prevalent HIV infection in virgins and adolescents in Kenya, Lesotho, and Tanzania. Ann Epidemiol 2007; 17:217-226.
18. Weiss HA, Plummer ML, Changalucha J, Mshana G, Shigongo ZS, Todd J, et al. Circumcision among adolescent boys in rural northwestern Tanzania. Trop Med Int Health 2008; 13:1054-1061.
19. Brewer DD, Potterat JJ, Roberts JM Jr, Brody S. Unhygienic male circumcision procedures and HIV transmission. S Afr Med J 2009; 99:11-12.
20. Siegfried N, Muller M, Deeks JJ, Volmink J. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev 2009:CD003362.
21. Weiss HA, Quigley MA, Hayes RJ. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS 2000; 14:2361-2370.
22. Cameron DW, Simonsen JN, D'Costa LJ, Ronald AR, Maitha GM, Gakinya MN, et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet 1989; 2:403-407.
23. Weiss HA, Thomas SL, Munabi SK, Hayes RJ. Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis. Sex Transm Infect 2006; 82:101- 109; discussion 110.
24. Tobian AA, Quinn TC. Herpes simplex virus type 2 and syphilis infections with HIV: an evolving synergy in transmission and prevention. Curr Opin HIV AIDS 2009; 4:294-299.
25. Bailey RC, Mehta SD. Circumcision's place in the vicious cycle involving herpes simplex virus type 2 and HIV. J Infect Dis 2009; 199:923-925.
26. Sobngwi-Tambekou J, Taljaard D, Lissouba P, Zarca K, Puren A, Lagarde E, et al. Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa. J Infect Dis 2009; 199:958-964.
27. Tobian AA, Serwadda D, Quinn TC, Kigozi G, Gravitt PE, Laeyendecker O, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med 2009; 360:1298-1309.
28. Gray R, Serwadda D, Tobian A, Makumbi F, Suntoke T, Kigozi G, et al. The Role of Genital Ulcer Disease in the Efficacy of Male Circumcision for HIV Prevention. In: Proceedings of the 16th Conference on Retroviruses and Opportunistic Infections; Montreal, Canada 2009.
29. Bailey RC. Scaling up circumcision programmes: the road from evidence to practice. In: 4th International AIDS Society Conference of HIV Pathogenesis, Treatment and Prevention; Sydney, Australia; 2007; abstract TUPL101.
30. Gray RH, Serwadda D, Tobian AA, Chen MZ, Makumbi F, Suntoke T, et al. Effects of genital ulcer disease and herpes simplex virus type 2 on the efficacy of male circumcision for HIV prevention: analyses from the Rakai trials. PLoS Med 2009; 6:e1000187.
31. UNAIDS/WHO/SACEMA Expert Group on Modelling the Impact and Cost of Male Circumcision for HIV Prevention. Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making? PLoS Med 2009; 6:e1000109.
32. Wawer MJ, Makumbi F, Kigozi G, Serwadda D, Watya S, Nalugoda F, et al. Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet 2009; 374:229-237.
33. Baeten JM, Donnell D, Kapiga SH, Ronald A, John-Stewart G, Inambao M, et al. Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples. AIDS 2010; 24:737-744.
34. Reynolds SJ. Male circumcision and the risks of female HIV and STI acquisition in Rakai, Uganda. In: Proceedings of the 13th Conference on Retroviruses and Opportunistic Infections; Denver, USA; 2006.
35. Weiss HA, Hankins CA, Dickson K. Male circumcision and risk of HIV infection in women: a systematic review and meta-analysis. Lancet Infect Dis 2009; 9:669-677.
36. Sobngwi-Tambekou J, Taljaard D, Nieuwoudt M, Lissouba P, Puren A, Auvert B. Male circumcision and Neisseria gonorrhoea, Chlamydia trachomatis and Trichomonas vaginalis: observations after a randomised controlled trial for HIV prevention. Sex Transm Infect 2009; 85:116-120.
37. Mehta SD, Moses S, Agot K, Parker C, Ndinya-Achola JO, Maclean I, et al. Adult male circumcision does not reduce the risk of incident Neisseria gonorrhoea, Chlamydia tracho-matis, or Trichomonas vaginalis infection: results from a randomized, controlled trial in Kenya. J Infect Dis 2009; 200:370-378.
38. Auvert B, Sobngwi-Tambekou J, Cutler E, Nieuwoudt M, Lissouba P, Puren A, et al. Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in orange farm, South Africa. J Infect Dis 2009; 199:14-19.
39. Bosch FX, Albero G, Castellsague X. Male circumcision, human papillomavirus and cervical cancer: from evidence to intervention. J Fam Plann Reprod Healthcare 2009; 35:5-7.
40. Van Howe RS. Sampling bias explains association between human papillomavirus and circumcision. J Infect Dis 2009; 200:832; author reply 833-834.
41. Weaver BA, Feng Q, Holmes KK, Kiviat N, Lee SK, Meyer C, et al. Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J Infect Dis 2004; 189:677-685.
42. Hernandez BY, Wilkens LR, Zhu X, McDuffie K, Thompson P, Shvetsov YB, et al. Circumcision and human papillomavirus infection in men: a site-specific comparison. J Infect Dis 2008; 197:787-794.
43. Nielson CM, Schiaffino MK, Dunne EF, Salemi JL, Giuliano AR. Associations between male anogenital human papillomavirus infection and circumcision by anatomic site sampled and lifetime number of female sex partners. J Infect Dis 2009; 199:7-13.
44. Lu B, Wu Y, Nielson CM, Flores R, Abrahamsen M, Papenfuss M, et al. Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: a prospective study. J Infect Dis 2009; 199:362-371.
45. Lajous M, Mueller N, Cruz-Valdez A, Aguilar LV, Franceschi S, Hernandez-Avila M, et al. Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol Biomarkers Prev 2005; 14:1710-1716.
46. Gray RH. Infectious disease: male circumcision for preventing HPV infection. Nat Rev Urol 2009; 6:298-299.
47. Templeton DJ, Millett GA, Grulich AE. Male circumcision to reduce the risk of HIV and sexually transmitted infections among men who have sex with men. Curr Opin Infect Dis 2010; 23:45-52.
48. Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, Buchbinder SP. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol 1999; 150:306-311.
49. Templeton DJ, Jin F, Prestage GP, Donovan B, Imrie JC, Kippax SC, et al. Circumcision and risk of sexually transmissible infections in a community-based cohort of HIV-negative homosexual men in Sydney, Australia. J Infect Dis 2009; 200:1813-1819.
50. Sanchez J, Guanira J, Lama JR, Goicochea P, Segura P, Montoya O. Circumcision among men who have sex with men in the Andean Region. Symposium: epidemiology: changing epidemiology of STD in MSM. In: Proceedings of the 17th International Society for Sexually Transmitted Disease Research; Seattle, Washington; 2007.
51. Lane T, Raymond HF, Dladla S, Rasethe J, Struthers H, McFarland W, et al. High HIV prevalence among men who have sex with men in Soweto, South Africa: results from the Soweto Men's Study. AIDS Behav 2009 [Epub ahead of print]. PMID 19662623.
52. Millett GA, Ding H, Lauby J, Flores S, Stueve A, Bingham T, et al. Circumcision status and HIV infection among Black and Latino men who have sex with men in 3 US cities. J Acquir Immune Defic Syndr 2007; 46:643-650. (Pubitemid 350191059)
53. Reisen CA, Zea MC, Poppen PJ, Bianchi FT. Male circumcision and HIV status among Latino immigrant MSM in New York City. J LGBT Health Res 2007; 3:29-36.
54. Jameson DR, Celum CL, Manhart L, Menza TW, Golden MR. The association between lack of circumcision and HIV, HSV-2, and other sexually transmitted infections among men who have sex with men. Sex Transm Dis 2009.
55. Millett GA, Flores SA, Marks G, Reed JB, Herbst JH. Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men: a meta-analysis. JAMA 2008; 300:1674-1684.
56. Anderson J, Wilson D, Templeton DJ, Grulich A, Carter R, Kaldor J. Cost-effectiveness of adult circumcision in a resource-rich setting for HIV prevention among men who have sex with men. J Infect Dis 2009; 200:1803-1812.
57. Ruan Y, Qian HZ, Li D, Shi W, Li Q, Liang H, et al. Willingness to becircumcised for preventing HIV among Chinese men who have sex with men. AIDS Patient Care STDS 2009; 23:315-321.
58. Begley EB, Jafa K, Voetsch AC, Heffelfinger JD, Borkowf CB, Sullivan PS. Willingness of men who have sex with men (MSM) in the United States to be circumcised as adults to reduce the risk of HIV infection. PLoS One 2008; 3:e2731.
59. WHO/UNAIDS. New data on male circumcision and HIV prevention: Policy and programme implications: conclusions and recommendations. In. Geneva: UNAIDS; 2007.
60. Clearinghouse on Male Circumcision for HIV Prevention. http:// www.malecircumcision.org/. [Accessed 15 December 2009]
61. Krieger JN, Bailey RC, Opeya JC, Ayieko BO, Opiyo FA, Omondi D, et al. Adult male circumcision outcomes: experience in a developing country setting. Urol Int 2007; 78:235-240.
62. KigoziG,Gray RH, Wawer MJ, SerwaddaD,MakumbiF, Watya S, et al. The safety of adult male circumcision in HIV-infected and uninfected men inRakai, Uganda. PLoS Med 2008; 5:e116.
63. Muula AS, Prozesky HW, Mataya RH, Ikechebelu JI. Prevalence of complications of male circumcision in Anglophone Africa: a systematic review. BMC Urol 2007; 7:4.
64. Weiss HA, Larke N, Halperin D, Schenker I. Complications of circumcision in male neonates, infants and children: a systematic review. BMC Urol 2010; 10:2.
65. WHO/UNAIDS/JHPIEGO. Manual for male circumcision under local anaesthesia. Geneva: World Health Organisation; 2006.
66. WHO. Male circumcision quality assurance: a guide to enhancing the safety and quality of services. Geneva: World Health Organisation; 2008.
67. Mehta SD, Gray RH, Auvert B, Moses S, Kigozi G, Taljaard D, et al. Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials. AIDS 2009; 23:1557-1564.
68. Agot KE, Kiarie JN, Nguyen HQ, Odhiambo JO, Onyango TM, Weiss NS. Male circumcision in Siaya and Bondo districts, Kenya: prospective cohort study to assess behavioral disinhibi-tion following circumcision. J Acquir Immune Defic Syndr 2007; 44:66-70.
69. Gray RH, Li X, Kigozi G, Serwadda D, Nalugoda F, Watya S, et al. The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda. AIDS 2007; 21:845-850.
70. Bailey RC. Male circumcision for HIV prevention: operations research priorities - an international consultation. Nairobi; 2009.
71. Kigozi G, Watya S, Polis CB, Buwembo D, Kiggundu V, Wawer MJ, et al. The effect of male circumcision on sexual satisfaction and function, results from a randomized trial of male circumcision for human immunodeficiency virus prevention, Rakai, Uganda. BJU Int 2008; 101:65-70.
72. Kigozi G, Lukabwe I, Kagaayi J, Wawer MJ, Nantume B, Nalugoda F, et al. Sexual satisfaction of women partners of circumcised men in a randomized trial of male circumcision in Rakai, Uganda. BJU Int 2009; 104:1698-1701.
73. Krieger JN, Mehta SD, Bailey RC, Agot K, Ndinya-Achola JO, Parker C, et al. Adult male circumcision: effects on sexual function and sexual satisfaction in Kisumu, Kenya. J Sex Med 2008; 5:2610-2622.
74. Kahn JG, Marseille E, Auvert B. Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med 2006; 3:e517.
75. Martin G, Bollinger L, Pandit-Rajani T, Tshelelo R, Nkambula R, Forsythe S, et al. Costing male circumcision in Lesotho, Swaziland, and Zambia: implications for the cost-effectiveness of circumcision as an HIV intervention. Washington, District of Columbia: USAID Health Policy Initiative; 2007.
76. Bollinger L, Stover J. The potential cost and impact of expanding male circumcision in 14 African countries. Washington, District of Columbia: USAID Health Policy Initiative; 2009.
77. Singh-Grewal D, Macdessi J, Craig J. Circumcision for the prevention of urinary tract infection in boys: a systematic review of randomised trials and observational studies. Arch Dis Child 2005; 90:853-858.
78. Progress in male circumcision scale-up: country implementation update. In: Clearinghouse on male circumcision for HIV Prevention. 2009. http://www.malecircumcision.org/. [Accessed December 15 2009]
79. De Bruyn G, Martinson N, Gray G. Male circumcision for HIV prevention: developments from sub-Saharan Africa. Expert Rev Anti Infect Ther 2010; 8:23-31.